Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases.
about
Neuropathological Staging of Brain Pathology in Sporadic Parkinson's disease: Separating the Wheat from the Chaff.Does selection for short sleep duration explain human vulnerability to Alzheimer's disease?The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases.Pathology of Neurodegenerative Diseases.Neurodegenerative Disease Transmission and Transgenesis in Mice.Microtubule affinity-regulating kinases are potential druggable targets for Alzheimer's disease.Cryo-EM structures of tau filaments from Alzheimer's disease.Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's disease.Sleep and Human Aging.Let's make microglia great again in neurodegenerative disorders.Modeling Prion-Like Processing of Tau Protein in Alzheimer's Disease for Pharmaceutical Development.A Protein Aggregation Inhibitor, Leuco-Methylthioninium Bis(Hydromethanesulfonate), Decreases α-Synuclein Inclusions in a Transgenic Mouse Model of Synucleinopathy.Oral Exposure to Paraquat Triggers Earlier Expression of Phosphorylated α-Synuclein in the Enteric Nervous System of A53T Mutant Human α-Synuclein Transgenic Mice.Potent prion-like behaviors of pathogenic α-synuclein and evaluation of inactivation methods.Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?Structural and Functional Brain Mapping Correlates of Impaired Eye Movement Control in Parkinsonian Syndromes: A Systems-Based Concept.Glucocerebrosidase deficiency promotes protein aggregation through dysregulation of extracellular vesiclesStructures of filaments from Pick's disease reveal a novel tau protein fold
P2860
Q37693339-50595E98-6CA8-4E30-9E6D-430214CDB99EQ37738358-42FD69C7-E212-4194-AF58-5F3F156BF8BCQ39052041-945C46DC-5C83-4E40-A41D-2DD696DE9D21Q39071493-30105A98-5B5D-458C-BAAD-4B9B37965EEEQ39134078-E4B6750F-D1B0-454F-8F1F-05AB79F45A26Q39387270-53B6D75F-BCCB-4AD0-A013-19148561852DQ41597304-A59A50A1-8DE2-401D-A1E6-E06E6DC555B1Q45305113-4A8586C5-ACF7-4096-81E5-E03FE932E4A4Q46025057-EB94622B-11F1-41F1-93BF-75F9D8496DAAQ46926746-CC3C3FB9-7F7C-47E2-94B0-B234587D603BQ47308968-83BB2824-D20A-4E75-B1D7-763640A5AA39Q47548619-F9017FD3-091A-4286-A8C3-1A433F6B53CEQ47639323-6796F57E-DFC3-4BF3-91D1-F3C63D12FDDFQ52718516-BE640D35-A928-4160-9BCA-39B7CD30BF80Q54982491-3FAEB3EC-5B64-45E6-B813-FFC23A613788Q55312617-64120694-7DEC-409D-A35E-85E4ACF2FD67Q58693990-46378B58-A935-4DDA-868D-6369AE3CC7F3Q59065184-DF1EFC97-F34E-487D-BF79-DDD55189B926
P2860
Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Potential Pathways of Abnormal ...... er's and Parkinson's Diseases.
@en
type
label
Potential Pathways of Abnormal ...... er's and Parkinson's Diseases.
@en
prefLabel
Potential Pathways of Abnormal ...... er's and Parkinson's Diseases.
@en
P2860
P1476
Potential Pathways of Abnormal ...... er's and Parkinson's Diseases.
@en
P2093
Heiko Braak
Kelly Del Tredici
P2860
P356
10.1101/CSHPERSPECT.A023630
P577
2016-08-31T00:00:00Z